Joint Association of Cardiovascular-Kidney-Metabolic Stage and Lifestyle With Mortality Among Cancer Survivors: A NHANES Cohort Study

Why It Matters

Identifying cancer survivors with advanced CKM and poor lifestyle pinpoints a high‑risk group that could benefit from targeted interventions, potentially improving survival and reducing heart‑disease deaths.

Key Takeaways

• Late CKM with poor lifestyle doubles mortality risk
• High lifestyle reduces risk even with late CKM
• Early CKM patients show similar survival across lifestyles
• Behavior-only LE8 score predicts survival across CKM stages
• Survivorship programs should integrate cardiometabolic staging

Pulse Analysis

Cancer survivorship has shifted from short‑term treatment success to long‑term health management, with cardiovascular and metabolic complications emerging as leading causes of death. The CKM staging framework, which aggregates cardiovascular, kidney and metabolic disease severity, offers clinicians a concise way to gauge systemic risk. Coupled with the Life’s Essential 8 metric—a composite of diet, physical activity, smoking, and sleep—researchers can now stratify patients not just by disease burden but also by actionable lifestyle factors, enabling more nuanced risk profiling.

The NHANES analysis revealed that late‑stage CKM patients who maintained a high‑quality lifestyle experienced a 50% increase in mortality risk compared with the healthiest reference group, whereas those with poor lifestyle habits faced more than double the risk. Notably, early‑stage CKM survivors showed comparable outcomes regardless of lifestyle, suggesting that disease stage drives mortality more than behavior until organ dysfunction advances. A dose‑response relationship across the behavior‑only LE8 score further underscored that incremental lifestyle improvements consistently lowered all‑cause death rates, even within high‑risk CKM strata.

These findings compel a redesign of survivorship programs to embed cardiometabolic staging and lifestyle counseling as standard components of follow‑up care. Primary care teams and oncology clinics should adopt routine CKM assessments, trigger referrals to nutritionists, exercise physiologists, and smoking cessation services, and monitor LE8 scores over time. Policymakers could incentivize integrated care pathways that align reimbursement with preventive metrics, while future research should explore whether intensive lifestyle interventions can reverse late‑stage CKM effects, potentially reshaping long‑term outcomes for millions of cancer survivors.